Lipid-Lowering Efficacy and Safety of a New Generic Rosuvastatin in Koreans: an 8-Week Randomized Comparative Study with a Proprietary Rosuvastatin

OBJECTIVE: The aim of this study was to investigate whether a new generic rosuvastatin is non-inferior to a proprietary one in terms of lipid-lowering efficacy. We also evaluated its non-lipid effects including adverse events. METHODS: One-hundred and fifty-eight patients with cardiovascular risks r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyoeun, Lee, Chan Joo, Choi, Donghoon, Kim, Byeong-Keuk, Kim, In-Cheol, Kim, Jung-Sun, Ahn, Chul-Min, Hong, Geu-Ru, Cho, In-Jeong, Shim, Chi-Young, Lee, Sang-Hak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Lipidology and Atherosclerosis 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379087/
https://www.ncbi.nlm.nih.gov/pubmed/32821737
http://dx.doi.org/10.12997/jla.2020.9.2.283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379087/
https://www.ncbi.nlm.nih.gov/pubmed/32821737
http://dx.doi.org/10.12997/jla.2020.9.2.283

Ejemplares similares